Giorgio Palù, President of the Italian Medicines Agency (Aifa), has resigned from his position, citing a “total lack of listening” by the Minister and the government. In a letter addressed to the board of directors of Aifa, Palù expressed his frustration and disappointment with the lack of harmony with the Minister and the absence of responses from the Government, forcing him to resign immediately.
“After careful reflection, I inform you that the lack of harmony with the Minister and the absence of responses from the Government force me to resign as appointed President of Aifa hic et immediate,” wrote Palù in his resignation letter. He also described his one-year assignment as “offensive and humiliating,” expressing his condemnation of the total lack of listening by the Minister in the choices made for Aifa.
The resignation of Palù comes as a shock to many in the medical and pharmaceutical community, as he was known for his leadership and dedication to the improvement of the Italian healthcare system. His decision to step down has raised concerns about the future of Aifa and the potential impact on the country’s healthcare policies.
The news of Palù’s resignation has sparked discussions about the level of communication and collaboration between health officials and government authorities in Italy. It also highlights the challenges and tensions within the healthcare sector, especially during a time of global health crisis.
As the country grapples with the ongoing COVID-19 pandemic and the need for effective healthcare management, the resignation of Palù raises important questions about the leadership and decision-making processes within the Italian healthcare system.
Reproduced with permission © Copyright ANSA.